Indo-MIM参加了MEDTEC JAPAN 2019，这是亚洲最大的医疗器械设计和制造行业展览和会议，于2019年3月18日至20日在东京举行。来自全球25个国家的560多家参展商展示了他们的最新技术和服务。日本是仅次于美国的世界第二大医疗器械市场。

来自近30个国家的35,000多名参观者参加了此次活动，其中包括美国，欧洲，东盟国家，中国，韩国等等。 Medtec Japan是一项针对性很强的活动，超过64％的访客来自医疗设备制造商

Indo-MIM第二次参加Medtec Japan，并获得了压倒性的反响。 Indo-MIM通过金属注射成型技术展示了为医疗行业生产的各种组件。 产品展示包括外科和矫形设备，如内窥镜缝合器，基于能量的血管封闭器，心血管设备，外科机器人和蛇腕机构的内窥镜尖端，脊柱和创伤植入物。参观者对这项创新技术的更多信息感到兴奋和好奇。 大量的医疗行业的OEM和一级供应商参观了展台，并对这项创新技术表现出了浓厚的兴趣。 MEDTEC Japan确实是展示MIM技术及其功能的绝佳平台。

By |2019-05-20T12:24:39+05:30May 20, 2019|Uncategorized|Comments Off on Medtec 2019 – Tokyo, Japan

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

Related Posts

DRHP-AV

DRHP-AV

Corporate Governance Policies

Corporate Governance Policies

Offer Documents

Offer Documents

Appointment Letters

Appointment Letters

Indo-MIM, 18 – 20 Mart 2019 tarihleri ​​arasında Tokyo’da düzenlenen Tıbbi Cihaz Tasarımı ve İmalatı endüstrisine adanmış Asya’nın en büyük fuar ve konferansı olan MEDTEC JAPAN 2019’a katıldı. Japonya, ABD’den sonra dünyanın en büyük ikinci tıbbi cihaz pazarı.Etkinliğe Amerika Birleşik Devletleri, Avrupa, ASEAN ülkeleri, Çin, Kore ve daha birçok ülkeden yaklaşık 30 ülkeden 35 binin üzerinde ziyaretçi katıldı. Medtec Japonya çok hedefli bir etkinlikti, tıbbi cihaz üreticilerinden gelen ziyaretçilerin% 64’ü Indo-MIM Medtec Japonya’ya ikinci kez katıldı ve çok büyük bir yanıt aldı. Indo-MIM, metal endüstrisi için metal enjeksiyon teknolojisi ile üretilen tüm bileşen çeşitlerini sergiledi. Ürün teşhirinde Endoskopik zımbalar, Enerji bazlı damar kapatıcılar, kardiyovasküler cihazlar, Cerrahi Robotlar ve yılan bilek mekanizmaları için endoskopik uçlar, Omurga ve travma implantları gibi cerrahi ve ortopedik cihazlar bulunmaktadır. Ziyaretçiler bu yenilikçi teknoloji hakkında daha fazla şey bilmek için heyecanlı ve meraklıydı. Tıbbi sektöre çok sayıda OEM ve Kademe 1 tedarikçileri standı ziyaret etti ve bu yenilikçi teknolojiye ilgi gösterdi. MEDTEC Japonya, MIM Teknolojisini ve yeteneklerini sergilemek için gerçekten harika bir platformdu.

By |2019-05-20T12:24:39+05:30May 20, 2019|Uncategorized|Comments Off on Medtec 2019 – Tokyo, Japan

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

Related Posts

DRHP-AV

DRHP-AV

Corporate Governance Policies

Corporate Governance Policies

Offer Documents

Offer Documents

Appointment Letters

Appointment Letters

white logo

SERVICES

SECTORS WE SERVE

COMPANY INFORMATION

Copyright @ 2024 INDO-MIM | All Rights Reserved

DISCLAIMER – IMPORTANT

PLEASE READ THIS NOTICE CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. VIEWING THIS INFORMATION MAY NOT BE LAWFUL IN CERTAIN JURISDICTIONS.

YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THE WEBSITE. BY ACCESSING THIS INFORMATION ON THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS BELOW, INCLUDING ANY MODIFICATIONS THAT MAY BE MADE TO THEM FROM TIME TO TIME

THE DRAFT RED HERRING PROSPECTUS HAS BEEN MADE AVAILABLE ON OUR WEBSITE TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the draft red herring prospectus of INDO-MIM Limited (the “Company”) dated September 26, 2025 (the “Draft Red Herring Prospectus”) filed with the Securities and Exchange Board of India (“SEBI”), BSE Limited, and the National Stock Exchange of India Limited and hosted on this website in connection with the initial public offering of the equity shares of the Company (the “Offer”).

Access to the Draft Red Herring Prospectus does not constitute a recommendation by the Company, the members of the Syndicate (as defined in the Draft Red Herring Prospectus) or any of their respective affiliates or any other person to subscribe to the Equity Shares offered in the Offer.

The Draft Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Draft Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Draft Red Herring Prospectus shall be copied or duplicated in any form by any means or redistributed.

The Draft Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. Our Company has taken all necessary steps to ensure that the contents of the Draft Red Herring Prospectus as appearing on this website are identical to the Draft Red Herring Prospectus filed with the SEBI, BSE Limited, and the National Stock Exchange of India Limited. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates, directors, agents, officers, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.

The Draft Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The securities described in the Draft Red Herring Prospectus have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the securities described in the Draft Red Herring Prospectus are being offered and sold (a) in the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to the private placement exemption set out in Section 4(a) of the U.S. Securities Act, and (b) outside the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdictions where those offers and sales are made. For the avoidance of doubt, the term “U.S. QIBs” does not refer to a category of institutional investors defined under applicable Indian regulations and referred to in this Draft Red Herring Prospectus as “QIBs”. There will be no public offering of such securities in the United States.

Any person into whose possession the Draft Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its affiliates is soliciting any action based on the Draft Red Herring Prospectus, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Draft Red Herring Prospectus for any investment decision.

Any decision on whether to invest in the securities described in the Draft Red Herring Prospectus may only be made after a Red Herring Prospectus has been filed with the Registrar of Companies, Karnataka at Bengaluru and the SEBI and must be made solely on the basis of such Red Herring Prospectus, as there may be material changes in the Red Herring Prospectus compared to the Draft Red Herring Prospectus. Invitations to subscribe to or purchase the equity shares in the Offer will be made only pursuant to the Red Herring Prospectus if the recipient is in India or the preliminary offering memorandum for the Offer, which comprises the Red Herring Prospectus and the preliminary international wrap for the Offer, if the recipient is outside India. No person outside India is eligible to Bid for equity shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which shall contain the selling restrictions for the Offer outside India.

Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section titled “Risk Factors” of the Draft Red Herring Prospectus. The Offer shall be made only pursuant to the Red Herring Prospectus, when available. Potential investors should also refer to the Red Herring Prospectus which will be filed with the Registrar of Companies, Karnataka at Bengaluru, and SEBI in the future, including the section titled “Risk Factors.”

Neither the Company nor any of its affiliates, directors, agents, officers, representatives, advisers, or employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Draft Red Herring Prospectus beyond the date of the Draft Red Herring Prospectus. The information contained in the Draft Red Herring Prospectus may not be updated since its original publication date and may not reflect the latest updates. The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

To access this information, you must confirm by pressing on the button marked "I Confirm" that, at the time of access you are located and resident in India. If you cannot make this confirmation, you must press the button marked "I Do Not Confirm".

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.

Current step:Step 1
Step 2
Go to Top